RIGEL PHARMACEUTICALS INC (RIGL) Fundamental Analysis & Valuation

NASDAQ:RIGL • US7665597024

Current stock price

26.59 USD
+0.46 (+1.76%)
Last:

This RIGL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. RIGL Profitability Analysis

1.1 Basic Checks

  • RIGL had positive earnings in the past year.
  • RIGL had a positive operating cash flow in the past year.
  • In multiple years RIGL reported negative net income over the last 5 years.
  • In multiple years RIGL reported negative operating cash flow during the last 5 years.
RIGL Yearly Net Income VS EBIT VS OCF VS FCFRIGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • The Return On Assets of RIGL (71.46%) is better than 99.42% of its industry peers.
  • RIGL's Return On Equity of 93.75% is amongst the best of the industry. RIGL outperforms 99.42% of its industry peers.
  • RIGL has a better Return On Invested Capital (23.92%) than 97.88% of its industry peers.
Industry RankSector Rank
ROA 71.46%
ROE 93.75%
ROIC 23.92%
ROA(3y)20.24%
ROA(5y)1.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIGL Yearly ROA, ROE, ROICRIGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400

1.3 Margins

  • RIGL's Profit Margin of 124.72% is amongst the best of the industry. RIGL outperforms 98.65% of its industry peers.
  • With an excellent Operating Margin value of 42.63%, RIGL belongs to the best of the industry, outperforming 98.65% of the companies in the same industry.
  • The Gross Margin of RIGL (93.33%) is better than 93.83% of its industry peers.
  • In the last couple of years the Gross Margin of RIGL has remained more or less at the same level.
Industry RankSector Rank
OM 42.63%
PM (TTM) 124.72%
GM 93.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.81%
GM growth 5Y-1.21%
RIGL Yearly Profit, Operating, Gross MarginsRIGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. RIGL Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RIGL is creating value.
  • Compared to 1 year ago, RIGL has more shares outstanding
  • RIGL has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, RIGL has an improved debt to assets ratio.
RIGL Yearly Shares OutstandingRIGL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
RIGL Yearly Total Debt VS Total AssetsRIGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • RIGL has an Altman-Z score of 1.29. This is a bad value and indicates that RIGL is not financially healthy and even has some risk of bankruptcy.
  • RIGL has a better Altman-Z score (1.29) than 63.58% of its industry peers.
  • The Debt to FCF ratio of RIGL is 0.69, which is an excellent value as it means it would take RIGL, only 0.69 years of fcf income to pay off all of its debts.
  • RIGL has a better Debt to FCF ratio (0.69) than 94.80% of its industry peers.
  • RIGL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • RIGL has a Debt to Equity ratio of 0.06. This is comparable to the rest of the industry: RIGL outperforms 41.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.69
Altman-Z 1.29
ROIC/WACC2.47
WACC9.69%
RIGL Yearly LT Debt VS Equity VS FCFRIGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • RIGL has a Current Ratio of 2.42. This indicates that RIGL is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.42, RIGL is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
  • A Quick Ratio of 2.30 indicates that RIGL has no problem at all paying its short term obligations.
  • RIGL's Quick ratio of 2.30 is on the low side compared to the rest of the industry. RIGL is outperformed by 69.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.3
RIGL Yearly Current Assets VS Current LiabilitesRIGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. RIGL Growth Analysis

3.1 Past

  • RIGL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 593.62%, which is quite impressive.
  • The Revenue has grown by 64.15% in the past year. This is a very strong growth!
  • RIGL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.06% yearly.
EPS 1Y (TTM)593.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
Revenue 1Y (TTM)64.15%
Revenue growth 3Y34.78%
Revenue growth 5Y22.06%
Sales Q2Q%21.19%

3.2 Future

  • RIGL is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.44% yearly.
  • The Revenue is expected to grow by 6.25% on average over the next years.
EPS Next Y-36.48%
EPS Next 2Y-13.06%
EPS Next 3Y-8.59%
EPS Next 5Y-2.44%
Revenue Next Year-3.09%
Revenue Next 2Y4.53%
Revenue Next 3Y6.64%
Revenue Next 5Y6.25%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RIGL Yearly Revenue VS EstimatesRIGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
RIGL Yearly EPS VS EstimatesRIGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

8

4. RIGL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 4.08 indicates a rather cheap valuation of RIGL.
  • RIGL's Price/Earnings ratio is rather cheap when compared to the industry. RIGL is cheaper than 99.04% of the companies in the same industry.
  • RIGL is valuated cheaply when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 6.42, the valuation of RIGL can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, RIGL is valued cheaply inside the industry as 98.46% of the companies are valued more expensively.
  • RIGL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.67.
Industry RankSector Rank
PE 4.08
Fwd PE 6.42
RIGL Price Earnings VS Forward Price EarningsRIGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, RIGL is valued cheaper than 99.04% of the companies in the same industry.
  • RIGL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RIGL is cheaper than 98.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.49
EV/EBITDA 2.08
RIGL Per share dataRIGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • RIGL has a very decent profitability rating, which may justify a higher PE ratio.
  • RIGL's earnings are expected to decrease with -8.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.06%
EPS Next 3Y-8.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RIGL Dividend Analysis

5.1 Amount

  • No dividends for RIGL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RIGL Fundamentals: All Metrics, Ratios and Statistics

RIGEL PHARMACEUTICALS INC

NASDAQ:RIGL (3/25/2026, 10:37:06 AM)

26.59

+0.46 (+1.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-03
Earnings (Next)05-04
Inst Owners91.09%
Inst Owner Change6.53%
Ins Owners3.09%
Ins Owner Change6.76%
Market Cap491.12M
Revenue(TTM)294.28M
Net Income(TTM)367.02M
Analysts80
Price Target47.94 (80.29%)
Short Float %21.33%
Short Ratio9.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.95%
Min EPS beat(2)-9.57%
Max EPS beat(2)67.46%
EPS beat(4)3
Avg EPS beat(4)168.74%
Min EPS beat(4)-9.57%
Max EPS beat(4)592.43%
EPS beat(8)6
Avg EPS beat(8)228.66%
EPS beat(12)10
Avg EPS beat(12)171.43%
EPS beat(16)13
Avg EPS beat(16)137.97%
Revenue beat(2)1
Avg Revenue beat(2)4.83%
Min Revenue beat(2)-0.39%
Max Revenue beat(2)10.05%
Revenue beat(4)3
Avg Revenue beat(4)10.23%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)19.17%
Revenue beat(8)6
Avg Revenue beat(8)10%
Revenue beat(12)10
Avg Revenue beat(12)7.75%
Revenue beat(16)12
Avg Revenue beat(16)11.69%
PT rev (1m)0%
PT rev (3m)3.68%
EPS NQ rev (1m)9.35%
EPS NQ rev (3m)9.35%
EPS NY rev (1m)7.12%
EPS NY rev (3m)-5.83%
Revenue NQ rev (1m)7.25%
Revenue NQ rev (3m)7.25%
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)-2.56%
Valuation
Industry RankSector Rank
PE 4.08
Fwd PE 6.42
P/S 1.67
P/FCF 6.49
P/OCF 6.49
P/B 1.25
P/tB 1.34
EV/EBITDA 2.08
EPS(TTM)6.52
EY24.52%
EPS(NY)4.14
Fwd EY15.58%
FCF(TTM)4.1
FCFY15.4%
OCF(TTM)4.1
OCFY15.4%
SpS15.93
BVpS21.2
TBVpS19.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number55.76
Profitability
Industry RankSector Rank
ROA 71.46%
ROE 93.75%
ROCE 30.28%
ROIC 23.92%
ROICexc 38.21%
ROICexgc 42.24%
OM 42.63%
PM (TTM) 124.72%
GM 93.33%
FCFM 25.71%
ROA(3y)20.24%
ROA(5y)1.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.81%
GM growth 5Y-1.21%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.69
Debt/EBITDA 0.18
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 19.09
Cash Conversion 59.16%
Profit Quality 20.61%
Current Ratio 2.42
Quick Ratio 2.3
Altman-Z 1.29
F-Score6
WACC9.69%
ROIC/WACC2.47
Cap/Depr(3y)409.8%
Cap/Depr(5y)265.74%
Cap/Sales(3y)4.35%
Cap/Sales(5y)2.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)593.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
EPS Next Y-36.48%
EPS Next 2Y-13.06%
EPS Next 3Y-8.59%
EPS Next 5Y-2.44%
Revenue 1Y (TTM)64.15%
Revenue growth 3Y34.78%
Revenue growth 5Y22.06%
Sales Q2Q%21.19%
Revenue Next Year-3.09%
Revenue Next 2Y4.53%
Revenue Next 3Y6.64%
Revenue Next 5Y6.25%
EBIT growth 1Y418.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-24.59%
EBIT Next 3Y32.03%
EBIT Next 5YN/A
FCF growth 1Y143.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.4%
OCF growth 3YN/A
OCF growth 5YN/A

RIGEL PHARMACEUTICALS INC / RIGL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of RIGEL PHARMACEUTICALS INC (RIGL) stock?

ChartMill assigns a fundamental rating of 6 / 10 to RIGL.


What is the valuation status for RIGL stock?

ChartMill assigns a valuation rating of 8 / 10 to RIGEL PHARMACEUTICALS INC (RIGL). This can be considered as Undervalued.


Can you provide the profitability details for RIGEL PHARMACEUTICALS INC?

RIGEL PHARMACEUTICALS INC (RIGL) has a profitability rating of 6 / 10.


How financially healthy is RIGEL PHARMACEUTICALS INC?

The financial health rating of RIGEL PHARMACEUTICALS INC (RIGL) is 6 / 10.